ZEISS unveils new AI-driven research data platform

(Image Credit: AdobeStock/kittyfly)

ZEISS has introduced its new ZEISS Research Data Platform (ZEISS RDP), a cloud-based, AI-driven solution designed to transform ophthalmic research workflows. The company noted a full introduction will be conducted at the upcoming ARVO meeting.

Euan S. Thomson, PhD, head of the digital business unit for ZEISS Medical Technology, commented on ZEISS RDP in a press release from the company.

"The future of healthcare is in the data. At ZEISS, we are delivering digital innovation to help shape the future of ophthalmology, investing in research methods that empower clinicians and researchers in balancing their clinical care and research requirements," said Thomson. "The introduction of the ZEISS RDP reflects our commitment to advancing ophthalmic care through smarter, AI-powered tools."

The ZEISS RDP “enables seamless integration of clinical and research data and empowers clinicians and scientists to accelerate discoveries through smarter, more efficient research.”

Attributes of the ZEISS RDP include the ability for clinicians and researchers to convert their research hypotheses into quantifiable biomarkers and to train their own algorithms and let AI handle complex, time-consuming data analysis, significantly improving efficiency.

The platform will also allow users to aggregate diverse datasets and formats from multiple sources and allow for a more “streamlined research workflow.”

Following a successful pilot phase, the company plans to launch the ZEISS RDP in select countries throughout 2025.

References:

1. ZEISS unveils AI-powered research data platform; collaboration with Boehringer Ingelheim champions the future of personalized eye care. Published May 1, 2025. Accessed May 1, 2025. https://www.zeiss.com/meditec-ag/en/media-news/press-releases/2025/research-data-platform.html